Osfirm


Osfirm Co., Ltd. is a South Korea–based medical device and biomaterials company founded in 2018. The company develops synthetic bone graft materials and implantable regenerative medical devices, conducts R&D in biomimetic inorganic materials (including whitlockite-based formulations), and collaborates with hospitals and universities for translational projects. It holds device-related certifications and multiple patents on biomaterial synthesis methods.

Industries

medical-device
product-research
therapeutics

Nr. of Employees

small (1-50)

Osfirm

Seongnam, Kyonggi-do, South Korea, Asia


Products

Nano-scale biocompatible raw material for medical devices

Nano-sized biocompatible inorganic material intended as a base material for medical devices and drug–device products.

Implantable bone graft materials

Resorbable bone graft products designed to support new bone formation and reconstruction of bone defects.

Biodegradable plates and screws for bone fixation

Bioresorbable fixation hardware intended to stabilize fractures while supporting bone regeneration and then degrade.

3D-printed patient-specific implants

Additively manufactured implants using biocompatible feedstock for cranial and other reconstructive indications.

Oral composition for dental sensitivity and wear

An oral care formulation intended to reduce excessive tooth wear and treat dental sensitivity.

Expertise Areas

  • Biomaterials development for bone regeneration
  • Implantable medical device development
  • 3D printing for patient-specific implants
  • Regulatory compliance and ISO 13485 quality systems
  • Show More (4)

Key Technologies

  • Whitlockite biomaterial formulations
  • Calcium phosphate particle-size control methods
  • Spatial and temporal separation synthesis techniques
  • Biomimetic inorganic nanoparticles
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.